Showing results (231-240 of 263) with videos related to
Sort By:
Pageof 27
Cancer Research|October 4, 2000
Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivoL M Butler, D B Agus, H I Scher, et al.The Journal of Biological Chemistry|April 12, 1996
Genistein is a natural inhibitor of hexose and dehydroascorbic acid transport through the glucose transporter, GLUT1J C Vera, A M Reyes, J G Cárcamo, et al.Critical Reviews in Oncology/Hematology|February 1, 1994
Bladder cancer: advances in biology and treatmentG J Bosl, W R Fair, H W Herr, et al.The Journal of Urology|March 1, 1988
Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for extravesical urinary tract tumorsH I Scher, A Yagoda, H W Herr, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 29, 2013
Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II studyS F Slovin, C S Higano, O Hamid, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 4, 2012
A phase I/IIA study of AGS-PSCA for castration-resistant prostate cancerM J Morris, M A Eisenberger, R Pili, et al.Nuclear Medicine and Biology|August 1, 1996
Detection of bony metastases of androgen-independent prostate cancer by PET-FDGS D Yeh, M Imbriaco, S M Larson, et al.Seminars in Nuclear Medicine|January 1, 1992
Rhenium-186 hydroxyethylidene diphosphonate for the treatment of painful osseous metastasesH R Maxon, S R Thomas, V S Hertzberg, et al.Journal of Neurology|June 1, 1994
The effects of an ACTH (4-9) analogue on development of cisplatin neuropathy in testicular cancer: a randomized trialJ M van Gerven, A Hovestadt, J W Moll, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1990
Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selectionG C Toner, D M Panicek, R T Heelan, et al.Pageof 27